QT
SLNO

Quantbot Technologies’s Soleno Therapeutics SLNO Stock Holding History

Quantbot Technologies’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,118
Closed -$144K – 2121
2025
Q4 		$144K Buy
3,118
+2,132
+216% +$117K ﹤0.01% 1326
2025
Q3 		$66.7K Buy
+986
New +$73.1K ﹤0.01% 1488
2025
Q1 		– Sell
-9
Closed -$405 – 1839
2024
Q4 		$405 Sell
9
-235
-96% -$12.2K ﹤0.01% 1414
2024
Q3 		$12.3K Buy
244
+240
+6,000% +$11.5K ﹤0.01% 1353
2024
Q2 		$163 Buy
+4
New +$170 ﹤0.01% 1369

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

Quantbot Technologies's SLNO Position: Q1 2026 in Review

Quantbot Technologies sold out of Soleno Therapeutics (SLNO) in Q1 2026, closing a stake of 3,118 shares — an estimated $144K sold.

Quantbot Technologies first reported a position in SLNO in Q2 2024 and held it in 5 quarters. The position peaked at $144K in Q4 2025. 226 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Quantbot Technologies reported no remaining Soleno Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 3,118 Soleno Therapeutics shares in Q1 2026, an estimated $144K.
  • Quantbot Technologies first reported a position in Soleno Therapeutics in Q2 2024 and held it in 5 quarters.
  • Quantbot Technologies's Soleno Therapeutics position peaked at $144K in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.